EGA Conference Krakow
4-6 October 2000
Speeches & Presentations
The Worldwide Role of Generic Pharmaceuticals: Accent on Access and Quality
- Dr. Lembit Rägo, Department of Essential Drugs and Medicines Policy,
Coordinator for Quality Assurance and Safety Medicines, WHO
• Presentation Slides (pdf 680 KB)
The Importance of Promoting Generic Medicines in Europe – The WHO View
- Mr. Kees de Joncheere, Regional Adviser for Pharmaceuticals, WHO
• Presentation Slides (pdf 500 KB)
Major Legal Developments Affecting the Generic Medicines Industry
• Data Exclusivity • "Is Marketed" • Testing & Experimental Use •
The Future of Generics Markets in Europe to 2010
Industrial Policy for the European Generic Medicines Industry – the Commission View
- Mr. Philippe Jean, Deputy Head of Cabinet, Commissioner Liikanen, EU Commission
• Conference Address (pdf 40 KB)
Patents, Data Exclusivity and Access to Medicines: A Civil Society View
- Ms. Ellen t’Hoen, Médecins Sans Frontières
• Presentation not available
Intellectual Property Issues and EU Accession
- Mr. Mihály Ficsor, Hungarian Patent Office, Head of Legal and International Department
• Conference Paper (pdf 99 KB)
The Centralised Procedure and Generics Applications
- Mr. Noël Wathion, Head of Sector Regulatory Affairs and Pharmacovigilance, EMEA
• Presentation not currently available
Implications of the 2001 Review for EU Accession Countries
- Prof. Tamás Paál, Head of the Hungarian National Institute of Pharmacy, Current Secretariat of CADREAC
• Presentation not currently available
<< Back
|
